Medical Care
Liver Failure Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 547886
- Pages: 108
- Figures: 184
- Views: 1
The global market for Liver Failure Therapeutics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liver Failure Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Liver Failure Therapeutics by region & country, by Type, and by Application.
The Liver Failure Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Failure Therapeutics.
Market Segmentation
By Company
Alfact Innovation
BioLineRx Ltd
Cell2B Advanced Therapeutics SA
Conatus Pharmaceuticals Inc
Immune Pharmaceuticals Inc
Mina Therapeutics Ltd
Mylan NV
Ocera Therapeutics Inc
PledPharma AB
Promethera Biosciences SA
Silence Therapeutics Plc
Unicyte AG
Ventria Bioscience
Vital Therapies Inc
Segment by Type:
Ornithine Phenylacetate
MTL-CEBPA
F-573
BL-1220
PP-100
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Liver Failure Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Liver Failure Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Liver Failure Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liver Failure Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Liver Failure Therapeutics by region & country, by Type, and by Application.
The Liver Failure Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Failure Therapeutics.
Market Segmentation
By Company
Alfact Innovation
BioLineRx Ltd
Cell2B Advanced Therapeutics SA
Conatus Pharmaceuticals Inc
Immune Pharmaceuticals Inc
Mina Therapeutics Ltd
Mylan NV
Ocera Therapeutics Inc
PledPharma AB
Promethera Biosciences SA
Silence Therapeutics Plc
Unicyte AG
Ventria Bioscience
Vital Therapies Inc
Segment by Type:
Ornithine Phenylacetate
MTL-CEBPA
F-573
BL-1220
PP-100
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Liver Failure Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Liver Failure Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Liver Failure Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Liver Failure Therapeutics Product Introduction
1.2 Global Liver Failure Therapeutics Market Size Forecast
1.3 Liver Failure Therapeutics Market Trends & Drivers
1.3.1 Liver Failure Therapeutics Industry Trends
1.3.2 Liver Failure Therapeutics Market Drivers & Opportunity
1.3.3 Liver Failure Therapeutics Market Challenges
1.3.4 Liver Failure Therapeutics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Liver Failure Therapeutics Players Revenue Ranking (2023)
2.2 Global Liver Failure Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Liver Failure Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Liver Failure Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Liver Failure Therapeutics
2.6 Liver Failure Therapeutics Market Competitive Analysis
2.6.1 Liver Failure Therapeutics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Liver Failure Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Failure Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Ornithine Phenylacetate
3.1.2 MTL-CEBPA
3.1.3 F-573
3.1.4 BL-1220
3.1.5 PP-100
3.1.6 Others
3.2 Global Liver Failure Therapeutics Sales Value by Type
3.2.1 Global Liver Failure Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Liver Failure Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Liver Failure Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinic
4.1.2 Hospital
4.1.3 Others
4.2 Global Liver Failure Therapeutics Sales Value by Application
4.2.1 Global Liver Failure Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Liver Failure Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Liver Failure Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Liver Failure Therapeutics Sales Value by Region
5.1.1 Global Liver Failure Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Liver Failure Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Liver Failure Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Liver Failure Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Liver Failure Therapeutics Sales Value, 2019-2030
5.2.2 North America Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Liver Failure Therapeutics Sales Value, 2019-2030
5.3.2 Europe Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Liver Failure Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Liver Failure Therapeutics Sales Value, 2019-2030
5.5.2 South America Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Liver Failure Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Liver Failure Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Liver Failure Therapeutics Sales Value
6.3 United States
6.3.1 United States Liver Failure Therapeutics Sales Value, 2019-2030
6.3.2 United States Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Liver Failure Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Liver Failure Therapeutics Sales Value, 2019-2030
6.4.2 Europe Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Liver Failure Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Liver Failure Therapeutics Sales Value, 2019-2030
6.5.2 China Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Liver Failure Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Liver Failure Therapeutics Sales Value, 2019-2030
6.6.2 Japan Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Liver Failure Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Liver Failure Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Liver Failure Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Liver Failure Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Liver Failure Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Liver Failure Therapeutics Sales Value, 2019-2030
6.9.2 India Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Liver Failure Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Alfact Innovation
7.1.1 Alfact Innovation Profile
7.1.2 Alfact Innovation Main Business
7.1.3 Alfact Innovation Liver Failure Therapeutics Products, Services and Solutions
7.1.4 Alfact Innovation Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 Alfact Innovation Recent Developments
7.2 BioLineRx Ltd
7.2.1 BioLineRx Ltd Profile
7.2.2 BioLineRx Ltd Main Business
7.2.3 BioLineRx Ltd Liver Failure Therapeutics Products, Services and Solutions
7.2.4 BioLineRx Ltd Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 BioLineRx Ltd Recent Developments
7.3 Cell2B Advanced Therapeutics SA
7.3.1 Cell2B Advanced Therapeutics SA Profile
7.3.2 Cell2B Advanced Therapeutics SA Main Business
7.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Products, Services and Solutions
7.3.4 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 Conatus Pharmaceuticals Inc Recent Developments
7.4 Conatus Pharmaceuticals Inc
7.4.1 Conatus Pharmaceuticals Inc Profile
7.4.2 Conatus Pharmaceuticals Inc Main Business
7.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Products, Services and Solutions
7.4.4 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.4.5 Conatus Pharmaceuticals Inc Recent Developments
7.5 Immune Pharmaceuticals Inc
7.5.1 Immune Pharmaceuticals Inc Profile
7.5.2 Immune Pharmaceuticals Inc Main Business
7.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Products, Services and Solutions
7.5.4 Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.5.5 Immune Pharmaceuticals Inc Recent Developments
7.6 Mina Therapeutics Ltd
7.6.1 Mina Therapeutics Ltd Profile
7.6.2 Mina Therapeutics Ltd Main Business
7.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Products, Services and Solutions
7.6.4 Mina Therapeutics Ltd Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.6.5 Mina Therapeutics Ltd Recent Developments
7.7 Mylan NV
7.7.1 Mylan NV Profile
7.7.2 Mylan NV Main Business
7.7.3 Mylan NV Liver Failure Therapeutics Products, Services and Solutions
7.7.4 Mylan NV Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.7.5 Mylan NV Recent Developments
7.8 Ocera Therapeutics Inc
7.8.1 Ocera Therapeutics Inc Profile
7.8.2 Ocera Therapeutics Inc Main Business
7.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Products, Services and Solutions
7.8.4 Ocera Therapeutics Inc Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.8.5 Ocera Therapeutics Inc Recent Developments
7.9 PledPharma AB
7.9.1 PledPharma AB Profile
7.9.2 PledPharma AB Main Business
7.9.3 PledPharma AB Liver Failure Therapeutics Products, Services and Solutions
7.9.4 PledPharma AB Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.9.5 PledPharma AB Recent Developments
7.10 Promethera Biosciences SA
7.10.1 Promethera Biosciences SA Profile
7.10.2 Promethera Biosciences SA Main Business
7.10.3 Promethera Biosciences SA Liver Failure Therapeutics Products, Services and Solutions
7.10.4 Promethera Biosciences SA Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.10.5 Promethera Biosciences SA Recent Developments
7.11 Silence Therapeutics Plc
7.11.1 Silence Therapeutics Plc Profile
7.11.2 Silence Therapeutics Plc Main Business
7.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Products, Services and Solutions
7.11.4 Silence Therapeutics Plc Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.11.5 Silence Therapeutics Plc Recent Developments
7.12 Unicyte AG
7.12.1 Unicyte AG Profile
7.12.2 Unicyte AG Main Business
7.12.3 Unicyte AG Liver Failure Therapeutics Products, Services and Solutions
7.12.4 Unicyte AG Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.12.5 Unicyte AG Recent Developments
7.13 Ventria Bioscience
7.13.1 Ventria Bioscience Profile
7.13.2 Ventria Bioscience Main Business
7.13.3 Ventria Bioscience Liver Failure Therapeutics Products, Services and Solutions
7.13.4 Ventria Bioscience Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.13.5 Ventria Bioscience Recent Developments
7.14 Vital Therapies Inc
7.14.1 Vital Therapies Inc Profile
7.14.2 Vital Therapies Inc Main Business
7.14.3 Vital Therapies Inc Liver Failure Therapeutics Products, Services and Solutions
7.14.4 Vital Therapies Inc Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.14.5 Vital Therapies Inc Recent Developments
8 Industry Chain Analysis
8.1 Liver Failure Therapeutics Industrial Chain
8.2 Liver Failure Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Liver Failure Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Liver Failure Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Liver Failure Therapeutics Product Introduction
1.2 Global Liver Failure Therapeutics Market Size Forecast
1.3 Liver Failure Therapeutics Market Trends & Drivers
1.3.1 Liver Failure Therapeutics Industry Trends
1.3.2 Liver Failure Therapeutics Market Drivers & Opportunity
1.3.3 Liver Failure Therapeutics Market Challenges
1.3.4 Liver Failure Therapeutics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Liver Failure Therapeutics Players Revenue Ranking (2023)
2.2 Global Liver Failure Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Liver Failure Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Liver Failure Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Liver Failure Therapeutics
2.6 Liver Failure Therapeutics Market Competitive Analysis
2.6.1 Liver Failure Therapeutics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Liver Failure Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Failure Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Ornithine Phenylacetate
3.1.2 MTL-CEBPA
3.1.3 F-573
3.1.4 BL-1220
3.1.5 PP-100
3.1.6 Others
3.2 Global Liver Failure Therapeutics Sales Value by Type
3.2.1 Global Liver Failure Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Liver Failure Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Liver Failure Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinic
4.1.2 Hospital
4.1.3 Others
4.2 Global Liver Failure Therapeutics Sales Value by Application
4.2.1 Global Liver Failure Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Liver Failure Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Liver Failure Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Liver Failure Therapeutics Sales Value by Region
5.1.1 Global Liver Failure Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Liver Failure Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Liver Failure Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Liver Failure Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Liver Failure Therapeutics Sales Value, 2019-2030
5.2.2 North America Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Liver Failure Therapeutics Sales Value, 2019-2030
5.3.2 Europe Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Liver Failure Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Liver Failure Therapeutics Sales Value, 2019-2030
5.5.2 South America Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Liver Failure Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Liver Failure Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Liver Failure Therapeutics Sales Value
6.3 United States
6.3.1 United States Liver Failure Therapeutics Sales Value, 2019-2030
6.3.2 United States Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Liver Failure Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Liver Failure Therapeutics Sales Value, 2019-2030
6.4.2 Europe Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Liver Failure Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Liver Failure Therapeutics Sales Value, 2019-2030
6.5.2 China Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Liver Failure Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Liver Failure Therapeutics Sales Value, 2019-2030
6.6.2 Japan Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Liver Failure Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Liver Failure Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Liver Failure Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Liver Failure Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Liver Failure Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Liver Failure Therapeutics Sales Value, 2019-2030
6.9.2 India Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Liver Failure Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Alfact Innovation
7.1.1 Alfact Innovation Profile
7.1.2 Alfact Innovation Main Business
7.1.3 Alfact Innovation Liver Failure Therapeutics Products, Services and Solutions
7.1.4 Alfact Innovation Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 Alfact Innovation Recent Developments
7.2 BioLineRx Ltd
7.2.1 BioLineRx Ltd Profile
7.2.2 BioLineRx Ltd Main Business
7.2.3 BioLineRx Ltd Liver Failure Therapeutics Products, Services and Solutions
7.2.4 BioLineRx Ltd Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 BioLineRx Ltd Recent Developments
7.3 Cell2B Advanced Therapeutics SA
7.3.1 Cell2B Advanced Therapeutics SA Profile
7.3.2 Cell2B Advanced Therapeutics SA Main Business
7.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Products, Services and Solutions
7.3.4 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 Conatus Pharmaceuticals Inc Recent Developments
7.4 Conatus Pharmaceuticals Inc
7.4.1 Conatus Pharmaceuticals Inc Profile
7.4.2 Conatus Pharmaceuticals Inc Main Business
7.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Products, Services and Solutions
7.4.4 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.4.5 Conatus Pharmaceuticals Inc Recent Developments
7.5 Immune Pharmaceuticals Inc
7.5.1 Immune Pharmaceuticals Inc Profile
7.5.2 Immune Pharmaceuticals Inc Main Business
7.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Products, Services and Solutions
7.5.4 Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.5.5 Immune Pharmaceuticals Inc Recent Developments
7.6 Mina Therapeutics Ltd
7.6.1 Mina Therapeutics Ltd Profile
7.6.2 Mina Therapeutics Ltd Main Business
7.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Products, Services and Solutions
7.6.4 Mina Therapeutics Ltd Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.6.5 Mina Therapeutics Ltd Recent Developments
7.7 Mylan NV
7.7.1 Mylan NV Profile
7.7.2 Mylan NV Main Business
7.7.3 Mylan NV Liver Failure Therapeutics Products, Services and Solutions
7.7.4 Mylan NV Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.7.5 Mylan NV Recent Developments
7.8 Ocera Therapeutics Inc
7.8.1 Ocera Therapeutics Inc Profile
7.8.2 Ocera Therapeutics Inc Main Business
7.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Products, Services and Solutions
7.8.4 Ocera Therapeutics Inc Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.8.5 Ocera Therapeutics Inc Recent Developments
7.9 PledPharma AB
7.9.1 PledPharma AB Profile
7.9.2 PledPharma AB Main Business
7.9.3 PledPharma AB Liver Failure Therapeutics Products, Services and Solutions
7.9.4 PledPharma AB Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.9.5 PledPharma AB Recent Developments
7.10 Promethera Biosciences SA
7.10.1 Promethera Biosciences SA Profile
7.10.2 Promethera Biosciences SA Main Business
7.10.3 Promethera Biosciences SA Liver Failure Therapeutics Products, Services and Solutions
7.10.4 Promethera Biosciences SA Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.10.5 Promethera Biosciences SA Recent Developments
7.11 Silence Therapeutics Plc
7.11.1 Silence Therapeutics Plc Profile
7.11.2 Silence Therapeutics Plc Main Business
7.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Products, Services and Solutions
7.11.4 Silence Therapeutics Plc Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.11.5 Silence Therapeutics Plc Recent Developments
7.12 Unicyte AG
7.12.1 Unicyte AG Profile
7.12.2 Unicyte AG Main Business
7.12.3 Unicyte AG Liver Failure Therapeutics Products, Services and Solutions
7.12.4 Unicyte AG Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.12.5 Unicyte AG Recent Developments
7.13 Ventria Bioscience
7.13.1 Ventria Bioscience Profile
7.13.2 Ventria Bioscience Main Business
7.13.3 Ventria Bioscience Liver Failure Therapeutics Products, Services and Solutions
7.13.4 Ventria Bioscience Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.13.5 Ventria Bioscience Recent Developments
7.14 Vital Therapies Inc
7.14.1 Vital Therapies Inc Profile
7.14.2 Vital Therapies Inc Main Business
7.14.3 Vital Therapies Inc Liver Failure Therapeutics Products, Services and Solutions
7.14.4 Vital Therapies Inc Liver Failure Therapeutics Revenue (US$ Million) & (2019-2024)
7.14.5 Vital Therapies Inc Recent Developments
8 Industry Chain Analysis
8.1 Liver Failure Therapeutics Industrial Chain
8.2 Liver Failure Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Liver Failure Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Liver Failure Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Liver Failure Therapeutics Market Trends
Table 2. Liver Failure Therapeutics Market Drivers & Opportunity
Table 3. Liver Failure Therapeutics Market Challenges
Table 4. Liver Failure Therapeutics Market Restraints
Table 5. Global Liver Failure Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Liver Failure Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Liver Failure Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Liver Failure Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Liver Failure Therapeutics
Table 10. Global Liver Failure Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Failure Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Liver Failure Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Liver Failure Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Liver Failure Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Liver Failure Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Liver Failure Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Liver Failure Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Liver Failure Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Liver Failure Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Liver Failure Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Liver Failure Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Liver Failure Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Liver Failure Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Liver Failure Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Liver Failure Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Liver Failure Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Liver Failure Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Liver Failure Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Liver Failure Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Alfact Innovation Basic Information List
Table 32. Alfact Innovation Description and Business Overview
Table 33. Alfact Innovation Liver Failure Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Liver Failure Therapeutics Business of Alfact Innovation (2019-2024)
Table 35. Alfact Innovation Recent Developments
Table 36. BioLineRx Ltd Basic Information List
Table 37. BioLineRx Ltd Description and Business Overview
Table 38. BioLineRx Ltd Liver Failure Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Liver Failure Therapeutics Business of BioLineRx Ltd (2019-2024)
Table 40. BioLineRx Ltd Recent Developments
Table 41. Cell2B Advanced Therapeutics SA Basic Information List
Table 42. Cell2B Advanced Therapeutics SA Description and Business Overview
Table 43. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Liver Failure Therapeutics Business of Cell2B Advanced Therapeutics SA (2019-2024)
Table 45. Cell2B Advanced Therapeutics SA Recent Developments
Table 46. Conatus Pharmaceuticals Inc Basic Information List
Table 47. Conatus Pharmaceuticals Inc Description and Business Overview
Table 48. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Liver Failure Therapeutics Business of Conatus Pharmaceuticals Inc (2019-2024)
Table 50. Conatus Pharmaceuticals Inc Recent Developments
Table 51. Immune Pharmaceuticals Inc Basic Information List
Table 52. Immune Pharmaceuticals Inc Description and Business Overview
Table 53. Immune Pharmaceuticals Inc Liver Failure Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Liver Failure Therapeutics Business of Immune Pharmaceuticals Inc (2019-2024)
Table 55. Immune Pharmaceuticals Inc Recent Developments
Table 56. Mina Therapeutics Ltd Basic Information List
Table 57. Mina Therapeutics Ltd Description and Business Overview
Table 58. Mina Therapeutics Ltd Liver Failure Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Liver Failure Therapeutics Business of Mina Therapeutics Ltd (2019-2024)
Table 60. Mina Therapeutics Ltd Recent Developments
Table 61. Mylan NV Basic Information List
Table 62. Mylan NV Description and Business Overview
Table 63. Mylan NV Liver Failure Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Liver Failure Therapeutics Business of Mylan NV (2019-2024)
Table 65. Mylan NV Recent Developments
Table 66. Ocera Therapeutics Inc Basic Information List
Table 67. Ocera Therapeutics Inc Description and Business Overview
Table 68. Ocera Therapeutics Inc Liver Failure Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Liver Failure Therapeutics Business of Ocera Therapeutics Inc (2019-2024)
Table 70. Ocera Therapeutics Inc Recent Developments
Table 71. PledPharma AB Basic Information List
Table 72. PledPharma AB Description and Business Overview
Table 73. PledPharma AB Liver Failure Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Liver Failure Therapeutics Business of PledPharma AB (2019-2024)
Table 75. PledPharma AB Recent Developments
Table 76. Promethera Biosciences SA Basic Information List
Table 77. Promethera Biosciences SA Description and Business Overview
Table 78. Promethera Biosciences SA Liver Failure Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Liver Failure Therapeutics Business of Promethera Biosciences SA (2019-2024)
Table 80. Promethera Biosciences SA Recent Developments
Table 81. Silence Therapeutics Plc Basic Information List
Table 82. Silence Therapeutics Plc Description and Business Overview
Table 83. Silence Therapeutics Plc Liver Failure Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Liver Failure Therapeutics Business of Silence Therapeutics Plc (2019-2024)
Table 85. Silence Therapeutics Plc Recent Developments
Table 86. Unicyte AG Basic Information List
Table 87. Unicyte AG Description and Business Overview
Table 88. Unicyte AG Liver Failure Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Liver Failure Therapeutics Business of Unicyte AG (2019-2024)
Table 90. Unicyte AG Recent Developments
Table 91. Ventria Bioscience Basic Information List
Table 92. Ventria Bioscience Description and Business Overview
Table 93. Ventria Bioscience Liver Failure Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Liver Failure Therapeutics Business of Ventria Bioscience (2019-2024)
Table 95. Ventria Bioscience Recent Developments
Table 96. Vital Therapies Inc Basic Information List
Table 97. Vital Therapies Inc Description and Business Overview
Table 98. Vital Therapies Inc Liver Failure Therapeutics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Liver Failure Therapeutics Business of Vital Therapies Inc (2019-2024)
Table 100. Vital Therapies Inc Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Liver Failure Therapeutics Downstream Customers
Table 104. Liver Failure Therapeutics Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Liver Failure Therapeutics Product Picture
Figure 2. Global Liver Failure Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Liver Failure Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Liver Failure Therapeutics Report Years Considered
Figure 5. Global Liver Failure Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Liver Failure Therapeutics Revenue in 2023
Figure 7. Liver Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Ornithine Phenylacetate Picture
Figure 9. MTL-CEBPA Picture
Figure 10. F-573 Picture
Figure 11. BL-1220 Picture
Figure 12. PP-100 Picture
Figure 13. Others Picture
Figure 14. Global Liver Failure Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Liver Failure Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Clinic
Figure 17. Product Picture of Hospital
Figure 18. Product Picture of Others
Figure 19. Global Liver Failure Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Liver Failure Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Liver Failure Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Liver Failure Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Liver Failure Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Liver Failure Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Liver Failure Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Liver Failure Therapeutics Sales Value (%), (2019-2030)
Figure 32. United States Liver Failure Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Liver Failure Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Liver Failure Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Liver Failure Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 38. China Liver Failure Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 40. China Liver Failure Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Liver Failure Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Liver Failure Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Liver Failure Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Liver Failure Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Liver Failure Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Liver Failure Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 50. India Liver Failure Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 52. India Liver Failure Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 53. Liver Failure Therapeutics Industrial Chain
Figure 54. Liver Failure Therapeutics Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Table 1. Liver Failure Therapeutics Market Trends
Table 2. Liver Failure Therapeutics Market Drivers & Opportunity
Table 3. Liver Failure Therapeutics Market Challenges
Table 4. Liver Failure Therapeutics Market Restraints
Table 5. Global Liver Failure Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Liver Failure Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Liver Failure Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Liver Failure Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Liver Failure Therapeutics
Table 10. Global Liver Failure Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Failure Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Liver Failure Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Liver Failure Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Liver Failure Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Liver Failure Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Liver Failure Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Liver Failure Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Liver Failure Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Liver Failure Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Liver Failure Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Liver Failure Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Liver Failure Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Liver Failure Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Liver Failure Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Liver Failure Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Liver Failure Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Liver Failure Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Liver Failure Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Liver Failure Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Alfact Innovation Basic Information List
Table 32. Alfact Innovation Description and Business Overview
Table 33. Alfact Innovation Liver Failure Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Liver Failure Therapeutics Business of Alfact Innovation (2019-2024)
Table 35. Alfact Innovation Recent Developments
Table 36. BioLineRx Ltd Basic Information List
Table 37. BioLineRx Ltd Description and Business Overview
Table 38. BioLineRx Ltd Liver Failure Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Liver Failure Therapeutics Business of BioLineRx Ltd (2019-2024)
Table 40. BioLineRx Ltd Recent Developments
Table 41. Cell2B Advanced Therapeutics SA Basic Information List
Table 42. Cell2B Advanced Therapeutics SA Description and Business Overview
Table 43. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Liver Failure Therapeutics Business of Cell2B Advanced Therapeutics SA (2019-2024)
Table 45. Cell2B Advanced Therapeutics SA Recent Developments
Table 46. Conatus Pharmaceuticals Inc Basic Information List
Table 47. Conatus Pharmaceuticals Inc Description and Business Overview
Table 48. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Liver Failure Therapeutics Business of Conatus Pharmaceuticals Inc (2019-2024)
Table 50. Conatus Pharmaceuticals Inc Recent Developments
Table 51. Immune Pharmaceuticals Inc Basic Information List
Table 52. Immune Pharmaceuticals Inc Description and Business Overview
Table 53. Immune Pharmaceuticals Inc Liver Failure Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Liver Failure Therapeutics Business of Immune Pharmaceuticals Inc (2019-2024)
Table 55. Immune Pharmaceuticals Inc Recent Developments
Table 56. Mina Therapeutics Ltd Basic Information List
Table 57. Mina Therapeutics Ltd Description and Business Overview
Table 58. Mina Therapeutics Ltd Liver Failure Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Liver Failure Therapeutics Business of Mina Therapeutics Ltd (2019-2024)
Table 60. Mina Therapeutics Ltd Recent Developments
Table 61. Mylan NV Basic Information List
Table 62. Mylan NV Description and Business Overview
Table 63. Mylan NV Liver Failure Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Liver Failure Therapeutics Business of Mylan NV (2019-2024)
Table 65. Mylan NV Recent Developments
Table 66. Ocera Therapeutics Inc Basic Information List
Table 67. Ocera Therapeutics Inc Description and Business Overview
Table 68. Ocera Therapeutics Inc Liver Failure Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Liver Failure Therapeutics Business of Ocera Therapeutics Inc (2019-2024)
Table 70. Ocera Therapeutics Inc Recent Developments
Table 71. PledPharma AB Basic Information List
Table 72. PledPharma AB Description and Business Overview
Table 73. PledPharma AB Liver Failure Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Liver Failure Therapeutics Business of PledPharma AB (2019-2024)
Table 75. PledPharma AB Recent Developments
Table 76. Promethera Biosciences SA Basic Information List
Table 77. Promethera Biosciences SA Description and Business Overview
Table 78. Promethera Biosciences SA Liver Failure Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Liver Failure Therapeutics Business of Promethera Biosciences SA (2019-2024)
Table 80. Promethera Biosciences SA Recent Developments
Table 81. Silence Therapeutics Plc Basic Information List
Table 82. Silence Therapeutics Plc Description and Business Overview
Table 83. Silence Therapeutics Plc Liver Failure Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Liver Failure Therapeutics Business of Silence Therapeutics Plc (2019-2024)
Table 85. Silence Therapeutics Plc Recent Developments
Table 86. Unicyte AG Basic Information List
Table 87. Unicyte AG Description and Business Overview
Table 88. Unicyte AG Liver Failure Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Liver Failure Therapeutics Business of Unicyte AG (2019-2024)
Table 90. Unicyte AG Recent Developments
Table 91. Ventria Bioscience Basic Information List
Table 92. Ventria Bioscience Description and Business Overview
Table 93. Ventria Bioscience Liver Failure Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Liver Failure Therapeutics Business of Ventria Bioscience (2019-2024)
Table 95. Ventria Bioscience Recent Developments
Table 96. Vital Therapies Inc Basic Information List
Table 97. Vital Therapies Inc Description and Business Overview
Table 98. Vital Therapies Inc Liver Failure Therapeutics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Liver Failure Therapeutics Business of Vital Therapies Inc (2019-2024)
Table 100. Vital Therapies Inc Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Liver Failure Therapeutics Downstream Customers
Table 104. Liver Failure Therapeutics Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Liver Failure Therapeutics Product Picture
Figure 2. Global Liver Failure Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Liver Failure Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Liver Failure Therapeutics Report Years Considered
Figure 5. Global Liver Failure Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Liver Failure Therapeutics Revenue in 2023
Figure 7. Liver Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Ornithine Phenylacetate Picture
Figure 9. MTL-CEBPA Picture
Figure 10. F-573 Picture
Figure 11. BL-1220 Picture
Figure 12. PP-100 Picture
Figure 13. Others Picture
Figure 14. Global Liver Failure Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Liver Failure Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Clinic
Figure 17. Product Picture of Hospital
Figure 18. Product Picture of Others
Figure 19. Global Liver Failure Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Liver Failure Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Liver Failure Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Liver Failure Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Liver Failure Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Liver Failure Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Liver Failure Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Liver Failure Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Liver Failure Therapeutics Sales Value (%), (2019-2030)
Figure 32. United States Liver Failure Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Liver Failure Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Liver Failure Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Liver Failure Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 38. China Liver Failure Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 40. China Liver Failure Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Liver Failure Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Liver Failure Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Liver Failure Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Liver Failure Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Liver Failure Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Liver Failure Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 50. India Liver Failure Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Liver Failure Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 52. India Liver Failure Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 53. Liver Failure Therapeutics Industrial Chain
Figure 54. Liver Failure Therapeutics Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232